Billion-dollar snack empires feasted on sky-high prices for years, only to beg for forgiveness with “affordability” pledges as sales cratered and wallets slammed shut.
Story Snapshot
- Major snack giants like Hershey, Mondelez, and PepsiCo hiked prices aggressively from 2021-2023 amid inflation, boosting profits while consumers reeled.
- By 2025, demand plunged—Hershey forecasts 36-38% EPS drop, Mondelez 10%—triggering sudden halts on hikes and affordability talk.
- GLP-1 drugs like Ozempic, health trends, and private-label rivals amplified the backlash, forcing a market reset.
- 43% of shoppers cut snacks; unit sales rose 1% as dollars fell, signaling value hunger over indulgence.
- Challenger brands like Utz gained share with better-for-you options, exposing giants’ delayed pivot.
Price Hikes Fueled Record Profits Amid Inflation Surge
PepsiCo executed multiple price rounds on Frito-Lay brands like Doritos and Cheetos through 2023. Hershey raised prices by 20 points over three years as cocoa costs tripled to $7.3 billion projected for 2025. Mondelez hiked 30 points while cost of sales climbed past $25 billion from $16 billion. These moves passed inflation straight to consumers, padding bottom lines during 2021-2023 economic pressures. Common sense dictates companies protect margins, yet relentless increases ignored shopper strain until volumes tanked.
Consumer Revolt and Volume Declines Force Reckoning
By April 2025, NielsenIQ reported 43% of U.S. shoppers slashed snack purchases, with 38% hunting promotions. Salty snacks hit $41.9 billion but dipped 0.3% in dollars over 52 weeks, while units grew 1%. Hershey projected unprecedented 36-38% EPS plunge; Mondelez eyed 10% drop. CEOs like Mondelez’s Dirk Van de Put blamed economics for volume falls, downplaying GLP-1 drugs initially. PepsiCo’s Ramon Laguarta halted hikes in 2023 after “multiple rounds.”
GLP-1 Drugs and Health Shifts Accelerate the Downturn
GLP-1 medications like Ozempic promise 3-5% U.S. calorie intake cuts by 2030, hammering calorie-dense snacks hardest. Barclays and Morgan Stanley analysts quantified the threat, though executives prioritized economic factors. FDA dye phase-outs and “Make America Healthy Again” pushes added regulatory heat on additives. Consumers, snacking 3+ times daily at 48.8%, now demand clean labels, portion control, and non-seed oils. This aligns with conservative values of personal responsibility over corporate excuses.
Private Labels and Challengers Steal Market Share
Private-label sales project $277 billion in 2025, surging as shoppers fled premium pricing. Utz Brands posted 3.4% Q3 2025 sales growth and 5.8% branded salty gains. Jackson’s CEO James Marino pushes avocado oil chips amid seed oil migrations. Crackers evolved to $11 billion with 1% growth, favoring filled varieties up 9.6%. Giants dominate but lose ground to value plays and better-for-you innovations. Facts show adaptability trumps entitlement—Utz proves smaller players thrive by listening first.
Industry Reset Prioritizes Value Over Indulgence
Snack inflation cools faster than food-at-home, with promotions stabilizing volumes short-term. Long-term, BFY shifts like protein, fiber, and natural channels define resilience. Unlike 2009’s recession profit rise for Hershey, 2025 demands true affordability, not rhetoric. Executives pivot post-windfalls, but common sense reveals greed met its match in informed buyers and rivals. Snacking endures as essential, yet smarter—rewarding fiscal discipline over fleeting hikes.
Sources:
https://foodinstitute.com/focus/investors-keep-the-faith-with-candy-giants-hershey-mondelez/
https://www.snackandbakery.com/articles/114108-state-of-the-industry-2025-chips-are-down-and-up
https://www.snackandbakery.com/articles/114148-state-of-the-industry-2025-crackers-keep-evolving
